Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Grillo-Lopez

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Biotechnology|January 5, 2002
Harnessing the power of antibodies for therapeutic applications was a question of timeA J Grillo-Lopez, A McClure, B K Dallaire
Investigational New Drugs|January 1, 1983
Diaziquone (AZQ)J F Bender, A J Grillo-Lopez, J G Posada
Cancer Treatment Reports|December 1, 1983
Phase II study of amsacrine gluconate in refractory leukemiaG A Omura, E F Winton, W R Vogler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracilG R Hudes, F LaCreta, R J DeLap, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant gliomaJ Maral, M Poisson, B F Pertuiset, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase II trial of diaziquone in patients with head and neck cancerF Muñiz, E Vélez-García, J A Neidhart, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Trimetrexate: clinical development of a nonclassical antifolateP J O'Dwyer, R J DeLap, S A King, et al.
Cancer Treatment Reports|March 1, 1986
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomasH S Greenberg, W D Ensminger, P B Layton, et al.
Cancer Research|November 15, 1988
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)J R Hardy, V J Harvey, J W Paxton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Biotechnology|January 5, 2002
Harnessing the power of antibodies for therapeutic applications was a question of timeA J Grillo-Lopez, A McClure, B K Dallaire
Investigational New Drugs|January 1, 1983
Diaziquone (AZQ)J F Bender, A J Grillo-Lopez, J G Posada
Cancer Treatment Reports|December 1, 1983
Phase II study of amsacrine gluconate in refractory leukemiaG A Omura, E F Winton, W R Vogler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracilG R Hudes, F LaCreta, R J DeLap, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant gliomaJ Maral, M Poisson, B F Pertuiset, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase II trial of diaziquone in patients with head and neck cancerF Muñiz, E Vélez-García, J A Neidhart, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Trimetrexate: clinical development of a nonclassical antifolateP J O'Dwyer, R J DeLap, S A King, et al.
Cancer Treatment Reports|March 1, 1986
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomasH S Greenberg, W D Ensminger, P B Layton, et al.
Cancer Research|November 15, 1988
Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921)J R Hardy, V J Harvey, J W Paxton, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of ametantrone acetate (NSC-287513)J G Kuhn, C E Balmer, T M Ludden, et al.
Pageof 2